← Eichor
Study identifier: NCT04532190 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder

Condition: Attention-Deficit/Hyperactivity Disorder (ADHD)  ·  Sponsor: University of Calgary

PhaseNA
Planned participants30
Who can joinAll sexes, 9 Years to 15 Years
Healthy volunteersNo

About this study

Attention-Deficit/Hyperactivity Disorder (ADHD) is characterized by poor attention, impulsivity, hyperactivity and emotional-motivational dysregulation. Here, we will test if theta burst repetitive transcranial magnetic stimulation (rTMS) can reduce the symptoms of ADHD.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (1)

Alberta Children's HospitalCalgary, Alberta, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04532190